Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy

Cited by papers we hold 6

• Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective · 2022
  No notice
• Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets · 2021
  No notice
• Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects · 2018
  No notice
• Mitochondrial metabolism and cancer · 2017
  No notice
• Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy · 2017
  No notice
• Roles of PFKFB3 in cancer · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.